Impaired gut barrier integrity and reduced colonic expression of free fatty acid receptors in patients with Parkinson’s disease
Neurological Sciences · 2024
DOI: 10.1007/s10072-024-07641-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Sciences, 2024. Verfasst von Peng-Hsiang Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Parkinson Disease, Receptors, G-Protein-Coupled, Colon. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Research Health Institutes, National Science and Technology Council, National Taiwan University Hospital.
Abstract (Originalsprache)
BACKGROUND: Altered gut metabolites, especially short-chain fatty acids (SCFAs), in feces and plasma are observed in patients with Parkinson's disease (PD). OBJECTIVE: We aimed to investigate the colonic expression of two SCFA receptors, free fatty acid receptor (FFAR)2 and FFAR3, and gut barrier integrity in patients with PD and correlations with clinical severity. METHODS: In this retrospective study, colonic biopsy specimens were collected from 37 PD patients and 34 unaffected controls. Of this cohort, 31 participants (14 PD, 17 controls) underwent a series of colon biopsies. Colonic expression of FFAR2, FFAR3, and the tight junction marker ZO-1 were assayed by immunofluorescence staining. The You Only Look Once (version 8, YOLOv8) algorithm was used for automated detection and segmentation of immunostaining signal. PD motor function was assessed with the Movement Disorder Society (MDS)-Unified Parkinson's Disease Rating Scale (UPDRS), and constipation was assessed using Rome-IV criteria. RESULTS: Compared with controls, PD patients had significantly lower colonic expression of ZO-1 (p < 0.01) and FFAR2 (p = 0.01). On serial biopsy, colonic expression of FFAR2 and FFAR3 was reduced in the pre-motor stage before PD diagnosis (both p < 0.01). MDS-UPDRS motor scores did not correlate with colonic marker levels. Constipation severity negatively correlated with colonic ZO-1 levels (r = -0.49, p = 0.02). CONCLUSIONS: Colonic expression of ZO-1 and FFAR2 is lower in PD patients compared with unaffected controls, and FFAR2 and FFAR3 levels decline in the pre-motor stage of PD. Our findings implicate a leaky gut phenomenon in PD and reinforce that gut metabolites may contribute to the process of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Computer Science & Information Engineering, National Taiwan University, Taipei, Taiwan.
- Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Förderung
- National Research Health Institutes
- National Science and Technology Council
- National Taiwan University Hospital
- National Taiwan University
Zitieren
APA
Liao, P. H., Tung, H. Y., Lim, W. S., Jang, J. R., Li, H., Shun, C. T., Chiu, H. M., Wu, M. S., & Lin, C. H. (2024). Impaired gut barrier integrity and reduced colonic expression of free fatty acid receptors in patients with Parkinson’s disease. Neurological Sciences. https://doi.org/10.1007/s10072-024-07641-2
Vancouver
Liao PH, Tung HY, Lim WS, Jang JR, Li H, Shun CT, et al. Impaired gut barrier integrity and reduced colonic expression of free fatty acid receptors in patients with Parkinson’s disease. Neurological Sciences. 2024. doi:10.1007/s10072-024-07641-2
BibTeX
@article{Liao2024,
author = {Liao, Peng-Hsiang and Tung, Hsiao-Yen and Lim, Wee Shin and Jang, Jyh-Shing Roger and Li, Hsun and Shun, Chia-Tung and Chiu, Han-Mo and Wu, Ming-Shiang and Lin, Chin-Hsien},
title = {Impaired gut barrier integrity and reduced colonic expression of free fatty acid receptors in patients with Parkinson’s disease},
journal = {Neurological Sciences},
year = {2024},
doi = {10.1007/s10072-024-07641-2}
}
EUVIMED